Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 161

The DOI matches its Crossref record.

Analysis of Genotypes and Amino Acid Residues 2209 to 2248 of the Ns5a Region of Hepatitis C Virus in Relation to the Response to Interferon–β Therapy

Open access
Kurosaki, M, Enomoto, N, Murakami, T, Sakuma, I, Asahina, Y, Yamamoto, C, Ikeda, T, Tozuka, S, Izumi, N, Marumo, F, Sato, C · 1997 · Hepatology

Abstract

In chronic hepatitis C virus (HCV) infection, genotypes other than genotype 1b of HCV (HCV–1b) and low serum HCV–RNA levels are known to be associated with favorable outcome of interferon alfa (IFN–α) therapy. In addition, we recently reported a close correlation between the number of mutations in amino acid sequences 2209 to 2248 of the nonstructual protein 5A gene (NS5A2209–2248) of HCV–1b and the response to IFN–α. In the present study, we analyzed these viral factors in relation to the efficacy to IFN–β, another type I IFN. The pretreatment sera of 40 patients treated with IFN–β intravenously at 6 MU daily for 42 days were studied. HCV genotypes, serum HCV–RNA levels, and the amino acid sequence of NS5A2209–2248 in HCV–1b were determined. A sustained complete response to IFN therapy occurred in none of the ten patients with the wild–type HCV–1b who had an NS5A2209–2248 sequence identical to the prototype HCV–1b and in none of the six patients with the intermediate–type HCV–1b that had 1 mutation. In contrast, complete responses occurred in the following: 4 of 6 patients with the mutant–type HCV–1b that had five to ten mutations; 6 of 13 patients with genotype 2a of HCV (HCV–2a); and 2 of 5 patients with genotype 2b of HCV (HCV–2b). Among patients with the mutant–type HCV–1b or genotype 2 of HCV (HCV–2) the rate of complete response was significantly higher (12 of 24 vs. 0 of 16 patients, P < .001) and HCV–RNA levels were significantly lower (4.5 [4.0–6.5] vs. 6 [4.5–6.5] log copies/mL, median [range]; P < .001) compared with patients with the wild–or the intermediate–type HCV–1b. Patients with the mutant–type HCV–1b or HCV–2 whose HCV–RNA levels were lower than 6 log copies/mL had a complete response rate of 75% (12 of 16 patients) in contrast to 0% (0 of 24 patients) of the others (P < .001). These results indicate that the mutant–type HCV–1b or HCV–2 are sensitive to IFN–β as well as IFN–α. In conclusion, the determination of HCV genotypes, NS5A2209–2248 of HCV–1b and serum HCV–RNA levels may facilitate the selection of patients with a high likelihood of response to IFN–β.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.510250343

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 161

Metadata

Authors
Kurosaki, M., Enomoto, N., Murakami, T., Sakuma, I., Asahina, Y., Yamamoto, C., Ikeda, T., Tozuka, S., Izumi, N., Marumo, F., & Sato, C.
Venue
Hepatology
Published
1997-03
Volume
25
Issue
3
Pages
750-753
ISSN
0270-9139 (ISSN-L)
OpenAlex
W1998238867
Cited by
161
References
0
FWCI
12.31
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Analysis of Genotypes and Amino Acid Residues 2209 to 2248 of the Ns5a Region of Hepatitis C Virus in Relation to the Response to Interferon–β Therapy. https://app.cochat.ai/papers/10.1002/hep.510250343
The paper
Kurosaki, M., Enomoto, N., Murakami, T., Sakuma, I., Asahina, Y., Yamamoto, C., Ikeda, T., Tozuka, S., Izumi, N., Marumo, F., & Sato, C. (1997). Analysis of Genotypes and Amino Acid Residues 2209 to 2248 of the Ns5a Region of Hepatitis C Virus in Relation to the Response to Interferon–β Therapy. Hepatology. https://doi.org/10.1002/hep.510250343

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.